OBJECTIVE: We sought to demonstrate that elevated first-trimester uric acid is associated with development of gestational diabetes mellitus (GDM). STUDY DESIGN: Uric acid was measured in 1570 plasma samples collected at mean gestational age of 8.9 +/- 2.5 weeks. The primary outcome was GDM, diagnosed by 3-hour glucose tolerance test using Carpenter and Coustan criteria or by a 1-hour value of > or =200 mg/dL. Logistic regression was performed, adjusting for relevant covariates. RESULTS: Almost half (46.6%) of the women with GDM had first-trimester uric acid concentrations in the highest quartile (>3.57-8.30 mg/dL). Women with uric acid in the highest quartile had a 3.25-fold increased risk (95% confidence interval, 1.35-7.83) of developing GDM after adjustment for body mass index and age. This effect was concentration dependent as risk increased with increasing uric acid quartiles (P = .003). CONCLUSION: First-trimester hyperuricemia is associated with an increased risk of developing GDM, independent of body mass index.
OBJECTIVE: We sought to demonstrate that elevated first-trimester uric acid is associated with development of gestational diabetes mellitus (GDM). STUDY DESIGN:Uric acid was measured in 1570 plasma samples collected at mean gestational age of 8.9 +/- 2.5 weeks. The primary outcome was GDM, diagnosed by 3-hour glucose tolerance test using Carpenter and Coustan criteria or by a 1-hour value of > or =200 mg/dL. Logistic regression was performed, adjusting for relevant covariates. RESULTS: Almost half (46.6%) of the women with GDM had first-trimester uric acid concentrations in the highest quartile (>3.57-8.30 mg/dL). Women with uric acid in the highest quartile had a 3.25-fold increased risk (95% confidence interval, 1.35-7.83) of developing GDM after adjustment for body mass index and age. This effect was concentration dependent as risk increased with increasing uric acid quartiles (P = .003). CONCLUSION: First-trimester hyperuricemia is associated with an increased risk of developing GDM, independent of body mass index.
Authors: Tae Woo Yoo; Ki Chul Sung; Hun Sub Shin; Byung Jin Kim; Bum Soo Kim; Jin Ho Kang; Man Ho Lee; Jung Ro Park; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim; Seung Ho Ryu; Dong Geuk Keum Journal: Circ J Date: 2005-08 Impact factor: 2.993
Authors: Thais de A Coutinho; Stephen T Turner; Patricia A Peyser; Lawrence F Bielak; Patrick F Sheedy; Iftikhar J Kullo Journal: Am J Hypertens Date: 2007-01 Impact factor: 2.689
Authors: G Di Cianni; C Lencioni; L Volpe; A Ghio; I Cuccuru; G Pellegrini; L Benzi; R Miccoli; S Del Prato Journal: Diabetes Metab Res Rev Date: 2007-02 Impact factor: 4.876
Authors: Robert W Powers; Lisa M Bodnar; Roberta B Ness; Katheryn M Cooper; Marcia J Gallaher; Michael P Frank; Ashi R Daftary; James M Roberts Journal: Am J Obstet Gynecol Date: 2006-01 Impact factor: 8.661
Authors: S Katherine Laughon; Janet Catov; Robert W Powers; James M Roberts; Robin E Gandley Journal: Am J Hypertens Date: 2011-01-20 Impact factor: 2.689
Authors: Yeyi Zhu; Dinesh K Barupal; Amanda L Ngo; Charles P Quesenberry; Juanran Feng; Oliver Fiehn; Assiamira Ferrara Journal: Diabetes Date: 2022-08-01 Impact factor: 9.337
Authors: Jenna L Riis; Stephanie H Cook; Nicole Letourneau; Tavis Campbell; Douglas A Granger; Gerald F Giesbrecht Journal: Front Endocrinol (Lausanne) Date: 2022-03-18 Impact factor: 5.555
Authors: Jessica Sheehan Tangren; Camille E Powe; Jeffrey Ecker; Kate Bramham; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani Journal: Clin J Am Soc Nephrol Date: 2018-02-22 Impact factor: 8.237